Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -1.539% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CCN(c1ccc(NC(=O)c2ccc(Cl)nc2)cc1)C(C)C
b.) O=C(N/N=C/C=C\c1ccccc1[N+](=O)[O-])c1ccncc1
c.) CC(=O)Nc1ccc(C(=O)NNC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2)cc1
d.) CCN1CCN(CNC(=O)c2cnccn2)CC1
e.) Nc1cc(-c2ccc(OC(F)(F)F)cc2)nn1-c1ccc(Cl)c(Cl)c1
Answer: a. CCN(c1ccc(NC(=O)c2ccc(Cl)nc2)cc1)C(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(c1ccc(NC(=O)c2ccc(Cl)nc2)cc1)C(C)C
CCN(c1ccc(NC(=O)c2ccc(Cl)nc2)cc1)C(C)C
6-chloro-N-[4-[ethyl(propan-2-yl)amino]phenyl]pyridine-3-carboxamide